X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3268) 3268
Publication (710) 710
Book Review (68) 68
Book Chapter (33) 33
Conference Proceeding (7) 7
Dissertation (5) 5
Book / eBook (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1660) 1660
index medicus (1383) 1383
cell cycle (1253) 1253
animals (1185) 1185
cell biology (1069) 1069
biochemistry & molecular biology (981) 981
cdk inhibitors (887) 887
phosphorylation (773) 773
cdk (754) 754
oncology (641) 641
cancer (595) 595
mice (544) 544
apoptosis (530) 530
cyclin-dependent kinases - metabolism (515) 515
expression (473) 473
proteins (465) 465
cdk inhibitor (451) 451
cyclin-dependent kinases (446) 446
cell-cycle (422) 422
female (402) 402
p27 (373) 373
cyclin-dependent kinase (372) 372
cell cycle proteins - metabolism (346) 346
cell line, tumor (346) 346
cyclin-dependent kinases - antagonists & inhibitors (331) 331
kinases (315) 315
cyclins - metabolism (303) 303
cell proliferation (298) 298
research (288) 288
article (280) 280
male (270) 270
signal transduction (264) 264
proliferation (257) 257
s-phase (256) 256
protein (246) 246
retinoblastoma protein (246) 246
genetics & heredity (241) 241
cell division (240) 240
cell cycle - physiology (239) 239
saccharomyces-cerevisiae (237) 237
cell cycle - drug effects (236) 236
analysis (231) 231
p21 (231) 231
protein binding (229) 229
cyclin (228) 228
molecular sequence data (226) 226
cell line (224) 224
gene expression (224) 224
activation (223) 223
biology (212) 212
mitosis (211) 211
amino acid sequence (209) 209
growth (207) 207
cell cycle proteins - genetics (205) 205
transcription (204) 204
differentiation (198) 198
mutation (198) 198
cells, cultured (196) 196
protein-serine-threonine kinases - metabolism (193) 193
cyclin-dependent kinase 2 (190) 190
cyclin-dependent kinase inhibitor p27 (189) 189
dependent kinase inhibitor (188) 188
cyclins (187) 187
gene-expression (186) 186
retinoblastoma protein - metabolism (185) 185
antineoplastic agents - pharmacology (184) 184
dependent kinases (182) 182
biophysics (178) 178
cyclin-dependent kinases - genetics (177) 177
research article (175) 175
cell proliferation - drug effects (172) 172
dna-replication (172) 172
apoptosis - drug effects (170) 170
p53 (169) 169
rats (169) 169
cdk-activating kinase (166) 166
dna replication (166) 166
cyclin-dependent kinase inhibitor p21 (164) 164
physiological aspects (163) 163
protein-kinase (163) 163
binding (160) 160
cyclins - genetics (160) 160
genetic aspects (160) 160
down-regulation (156) 156
in-vivo (156) 156
cycle (155) 155
pharmacology & pharmacy (155) 155
g1 phase (152) 152
in-vitro (152) 152
budding yeast (149) 149
cell cycle proteins (143) 143
hela cells (143) 143
blotting, western (142) 142
tumor cells, cultured (141) 141
breast cancer (139) 139
breast-cancer (139) 139
gene (139) 139
cyclin-dependent kinase inhibitor p27 - metabolism (138) 138
enzyme inhibitors - pharmacology (136) 136
kinase (136) 136
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3292) 3292
Japanese (25) 25
French (4) 4
Czech (3) 3
Chinese (2) 2
German (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2018, Volume 171, Issue 1, pp. 11 - 20
Journal Article
Cancer Science, ISSN 1347-9032, 04/2019, Volume 110, Issue 4, pp. 1420 - 1430
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5802 - 5813
Purpose: Bioinformatics analysis followed by in vivo studies in patient-derived xenograft (PDX) models were used to identify and validate CDK4/6 inhibition as... 
CELLS | DEPENDENT KINASE 4/6 | GLIOBLASTOMA XENOGRAFT | CDK6 | ONCOLOGY | ANTITUMOR-ACTIVITY | IDENTIFICATION | PD 0332991 | PHASE-I | CYCLIN | PROGRESSION | Piperazines - administration & dosage | Phosphorylation | Prognosis | Pyridines - administration & dosage | Protein Interaction Maps - drug effects | Cyclin-Dependent Kinase 4 - genetics | Humans | Signal Transduction - genetics | Molecular Targeted Therapy | Xenograft Model Antitumor Assays | Animals | Hedgehog Proteins - genetics | Protein Interaction Maps - genetics | Medulloblastoma - pathology | Cell Proliferation - drug effects | Mice | Proto-Oncogene Proteins c-myc - genetics | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Medulloblastoma - drug therapy | Medulloblastoma - genetics | Cyclin D - genetics | Disease Models, Animal | Cerebellum | Surgical implants | Animal models | Target recognition | Myc protein | Cyclin-dependent kinase 4 | Subgroups | Xenografts | Cyclin D | Inhibition | Bioinformatics | Informatics | Regression analysis | Survival | Amplification | Mutagenesis | Experimental design | Hedgehog protein | Medulloblastoma | Medical prognosis | In vivo methods and tests | Tumors | Cancer | Kinase and phosphatase inhibitors | Brain | Xenograft models | Cell cyle mechanisms of anticancer drug action | Phosphorylation and proteolysis in cell cycle control | Rb and family | Cyclins | central nervous system cancers | CDKs and CDK inhibitors | Control of cell cycle progression
Journal Article
Journal Article
Journal Article
Breast Cancer, ISSN 1340-6868, 7/2018, Volume 25, Issue 4, pp. 402 - 406
Endocrine therapy is the mainstay of treatment for patients with estrogen receptor positive (ER+)/HER2-negative (HER2−) metastatic breast cancer (MBC). Many... 
Abemaciclib | Ribocciclib | Medicine & Public Health | Surgery | Palbociclib | Oncology | Cancer Research | CDK inhibitors | Surgical Oncology | Breast Cancer | COMBINATION | OBSTETRICS & GYNECOLOGY | KINASE 4/6 INHIBITOR | RIBOCICLIB | SINGLE-AGENT | THERAPY | ONCOLOGY | LETROZOLE | JAPANESE PATIENTS | PHASE-I | Breast cancer | Estrogen | Metastasis
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2005, Volume 48, Issue 7, pp. 2388 - 2406
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 21, pp. 15658 - 15672
High grade serous ovarian cancer (HGSOC) is a disease with a high relapse rate and poor overall survival despite good initial responses to platinum-based... 
Ribociclib | Chemotherapy resistance | CDK 4/6 inhibitor | Cell cycle | Ovarian cancer
Journal Article